Wohlkoenig C - Search Results

1

Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.

Li Y, Connolly M, Nagaraj C, Tang B, Bálint Z, Popper H, Smolle-Juettner FM, Lindenmann J, Kwapiszewska G, Aaronson PI, Wohlkoenig C, Leithner K, Olschewski H, Olschewski A. Li Y, et al. Among authors: wohlkoenig c. Am J Respir Cell Mol Biol. 2012 Mar;46(3):372-9. doi: 10.1165/rcmb.2010-0428OC. Epub 2011 Oct 20. Am J Respir Cell Mol Biol. 2012. PMID: 22021335

2

Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.

Fischer C, Leithner K, Wohlkoenig C, Quehenberger F, Bertsch A, Olschewski A, Olschewski H, Hrzenjak A. Fischer C, et al. Among authors: wohlkoenig c. Mol Cancer. 2015 Jan 21;14:4. doi: 10.1186/1476-4598-14-4. Mol Cancer. 2015. PMID: 25608569 Free PMC article.

3

TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α.

Wohlkoenig C, Leithner K, Olschewski A, Olschewski H, Hrzenjak A. Wohlkoenig C, et al. Lung Cancer. 2017 Sep;111:15-22. doi: 10.1016/j.lungcan.2017.06.013. Epub 2017 Jun 21. Lung Cancer. 2017. PMID: 28838387

4

PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.

Leithner K, Hrzenjak A, Trötzmüller M, Moustafa T, Köfeler HC, Wohlkoenig C, Stacher E, Lindenmann J, Harris AL, Olschewski A, Olschewski H. Leithner K, et al. Among authors: wohlkoenig c. Oncogene. 2015 Feb 19;34(8):1044-50. doi: 10.1038/onc.2014.47. Epub 2014 Mar 17. Oncogene. 2015. PMID: 24632615

5

Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.

Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H. Leithner K, et al. Among authors: wohlkoenig c. Lung Cancer. 2009 Jul;65(1):98-104. doi: 10.1016/j.lungcan.2008.10.015. Epub 2008 Dec 9. Lung Cancer. 2009. PMID: 19081160

6

Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.

Wohlkoenig C, Leithner K, Deutsch A, Hrzenjak A, Olschewski A, Olschewski H. Wohlkoenig C, et al. Cancer Lett. 2011 Sep 28;308(2):134-43. doi: 10.1016/j.canlet.2011.03.014. Epub 2011 Jun 12. Cancer Lett. 2011. PMID: 21669489

7

Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.

Leithner K, Wohlkoenig C, Stacher E, Lindenmann J, Hofmann NA, Gallé B, Guelly C, Quehenberger F, Stiegler P, Smolle-Jüttner FM, Philipsen S, Popper HH, Hrzenjak A, Olschewski A, Olschewski H. Leithner K, et al. Among authors: wohlkoenig c. BMC Cancer. 2014 Jan 25;14:40. doi: 10.1186/1471-2407-14-40. BMC Cancer. 2014. PMID: 24460801 Free PMC article.

8

Positional therapy in sleep apnoea - one fits all? What determines success in positional therapy in sleep apnoea syndrome.

Troester N, Palfner M, Dominco M, Wohlkoenig C, Schmidberger E, Trinker M, Avian A. Troester N, et al. Among authors: wohlkoenig c. PLoS One. 2017 Apr 13;12(4):e0174468. doi: 10.1371/journal.pone.0174468. eCollection 2017. PLoS One. 2017. PMID: 28406975 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters